BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21813963)

  • 1. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance.
    Seppenwoolde Y; Wunderink W; Wunderink-van Veen SR; Storchi P; Méndez Romero A; Heijmen BJ
    Phys Med Biol; 2011 Sep; 56(17):5445-68. PubMed ID: 21813963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liver-implanted fiducial markers.
    Wunderink W; Méndez Romero A; Seppenwoolde Y; de Boer H; Levendag P; Heijmen B
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1573-83. PubMed ID: 20399034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies.
    Fuss M; Salter BJ; Cavanaugh SX; Fuss C; Sadeghi A; Fuller CD; Ameduri A; Hevezi JM; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1245-56. PubMed ID: 15234062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of fiducial markers in the liver for stereotactic body radiation therapy: Feasibility and results.
    Oldrini G; Taste-George H; Renard-Oldrini S; Baumann AS; Marchesi V; Troufléau P; Peiffert D; Didot-Moisei A; Boyer B; Grignon B; Henrot P
    Diagn Interv Imaging; 2015 Jun; 96(6):589-92. PubMed ID: 24613392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of applying diaphragm matching with the breath-holding technique in stereotactic body radiation therapy for liver tumors.
    Kawahara D; Ozawa S; Kimura T; Nakashima T; Aita M; Tsuda S; Ochi Y; Okumura T; Masuda H; Ohno Y; Murakami Y; Nagata Y
    Phys Med; 2016 Apr; 32(4):557-61. PubMed ID: 27012541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial fiducial marker placement: a novel technique.
    Young S; Vogel J; Wiley S; Caridi J
    J Vasc Interv Radiol; 2013 May; 24(5):756-8. PubMed ID: 23622051
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
    Jung J; Kim H; Yoon SM; Cho B; Kim YJ; Kwak J; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):867-874. PubMed ID: 29934276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiducial marker guided stereotactic liver radiotherapy: Is a time delay between marker implantation and planning CT needed?
    Worm ES; Bertholet J; Høyer M; Fledelius W; Hansen AT; Larsen LP; Nielsen JE; Poulsen PR
    Radiother Oncol; 2016 Oct; 121(1):75-78. PubMed ID: 27555229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).
    Kitamura K; Shirato H; Shimizu S; Shinohara N; Harabayashi T; Shimizu T; Kodama Y; Endo H; Onimaru R; Nishioka S; Aoyama H; Tsuchiya K; Miyasaka K
    Radiother Oncol; 2002 Mar; 62(3):275-81. PubMed ID: 12175558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving metal artifact reduction in cone-beam CT scans with implanted cylindrical gold markers.
    Toftegaard J; Fledelius W; Seghers D; Huber M; Brehm M; Worm ES; Elstrøm UV; Poulsen PR
    Med Phys; 2014 Dec; 41(12):121710. PubMed ID: 25471957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
    Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy.
    Beaton L; Daly M; Tregidgo HF; Grimes H; Moinuddin S; Stacey C; Znati S; Hague J; Bascal ZA; Wilde PE; Cooper S; Bandula S; Lewis AL; Clarkson MJ; Sharma RA
    Br J Radiol; 2022 Feb; 95(1130):20210594. PubMed ID: 34762499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-line use of three-dimensional marker trajectory estimation from cone-beam computed tomography projections for precise setup in radiotherapy for targets with respiratory motion.
    Worm ES; Høyer M; Fledelius W; Nielsen JE; Larsen LP; Poulsen PR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e145-51. PubMed ID: 22516384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy.
    Hawkins MA; Brock KK; Eccles C; Moseley D; Jaffray D; Dawson LA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):610-9. PubMed ID: 16966004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography.
    van der Horst A; Wognum S; Dávila Fajardo R; de Jong R; van Hooft JE; Fockens P; van Tienhoven G; Bel A
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):202-8. PubMed ID: 23790774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) - the ESMERALDA trial.
    Habermehl D; Naumann P; Bendl R; Oelfke U; Nill S; Debus J; Combs SE
    Radiat Oncol; 2015 Jul; 10():143. PubMed ID: 26169281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfractional positional variability of fiducial markers and primary tumors in locally advanced non-small-cell lung cancer during audiovisual biofeedback radiotherapy.
    Roman NO; Shepherd W; Mukhopadhyay N; Hugo GD; Weiss E
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1566-72. PubMed ID: 22391105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.